SCTX

12.1608.02%
DL

David L. Parrot

CFO & Treasurer

Mr. David L. Parrot, M.B.A, serves as Chief Financial Officer of Scribe Therapeutics Inc. since December 2021 and serves as its Treasurer. He joined Scribe Therapeutics Inc. in March 2022. He served as Managing Director and Head of Healthcare Investment Banking at Montgomery & Co., LLC. He joins Scribe from Barclays, where he was a Managing Director. An accomplished finance executive with experience within the high-growth biotechnology sector, he has extensive financial leadership in strategic advisory services and capital raising to Scribe’s work to further develop its proprietary platform for CRISPR-based genetic medicine. Mr. Parrot is responsible for the direction of Montgomery’s healthcare practice. He was Former Barclays Head of west coast biotech franchise. Mr. Parrot has investment banking experience with focused on the Life Science sector. He was Head of Life Science Investment Banking at SunTrust Robinson Humphrey. Prior to joining Montgomery, Mr. Parrot was a Managing Director for the biopharmaceutical investment banking franchise at Piper Jaffray & Co. in 1998 where he helped oversee their U.S. biopharmaceutical sector operations and led transactions across product areas including M&A, Partnership advisory, private placements, Registered Direct/PIPE offerings, public equity including IPOs and follow-on offerings and convertible securities. Before joining Barclays’ Life Science Investment Banking Group, Mr. Parrot was a Managing Director of Investment Banking in the Healthcare Group at SunTrust Robinson Humphrey, focused on the biotechnology sector. He began his career in investment banking at Piper Jaffray. Prior to joining SunTrust in 2015, Mr. Parrot was Co-Head of Life Science Investment Banking at BMO Capital Markets. Mr. Parrot joined BMO Capital Markets in from July 2010 to December 2014. He previously worked in the Life Sciences Investment Banking Group at Genesis Merchant Group Securities and in both the Debt Capital Markets and West Coast Corporate Coverage groups at SBC Warburg Dillon Reed, which was acquired by UBS in 1997. Mr. Parrot holds a B.A. in Economics from Middlebury College and holds an MBA from the University of California, Berkeley, Haas School of Business.

Positions